AVNT
Avient Corporation
NYSE · Basic Materials · Chemicals - Specialty · US
$43.27
+0.84%Year over year
Reported trailing growth
- Revenue
- +2.4%
- EBITDA
- +13.7%
- EBIT
- +24.5%
- EPS
- +43.1%
- Free cash flow
- -63.6%
- Operating cash flow
- -36.2%
Forward estimates
Based on analyst estimates
- Revenue
- +5.1%
- EBITDA
- -12.7%
- EPS
- +75.8%
Three-year CAGR
- Revenue
- -1.4%
- EBITDA
- +16.5%
- EBIT
- -5.8%
- Net income
- -18.8%
- EPS
- -51.1%
- Free cash flow
- -12.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026